ClinicalTrials.Veeva

Menu
C

California Neuropsychopharmacology Clinical Research Institute | CNRI San Diego, CA

Research site

Site insights

Top conditions

Top treatments

Lurasidone
SEP-363856
Cariprazine
RO6889450
KarXT
Ralmitaront
Aripiprazole
BMS-820836
ASP4345
Quetiapine fumarate

Parent organization

This site is a part of California Neuropsychopharmacology Clinical Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

CNRI San Diego, CA

Verified by this site

Active trials

2 of 32 total trials

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

ML-007C-MA-212 is a 52-week open-label study designed to evaluate the long-term safety, tolerability, and effectiveness of ML-007C-MA in participants...

Enrolling
Schizophrenia
Drug: ML-007C-MA

The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological sympt...

Enrolling
Schizophrenia
Drug: Placebo
Drug: NBI-1117568

Trial sponsors

Otsuka logo
Sumitomo Pharma logo
Bristol-Myers Squibb (BMS) logo
Forest Laboratories logo
Karuna Therapeutics logo
Roche logo
AbbVie logo
Alkermes logo
Astellas logo
AstraZeneca logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems